말 헬스케어 시장 규모, 점유율, 동향 분석 보고서 : 제품별, 적응증별, 활동별, 유통 채널별, 지역별, 부문별 예측(2025-2033년)

Equine Healthcare Market Summary

The global equine healthcare market size was estimated at USD 3.22 billion in 2024 and is projected to reach USD 6.41 billion by 2033, growing at a CAGR of 8.20% from 2025 to 2033. The market growth is primarily owing to a high equine population worldwide, advancements in veterinary technology and medicine, increasing sports activities, and awareness of nutrition and preventive healthcare.

For instance, according to the survey data published by the American Horse Council in 2024, over 6.6 million horses were recorded in the U.S. in 2023. Thus, a high population is expected to spur the demand for effective equine healthcare, thereby accelerating market growth potential in the country. Growing demand for advanced equine healthcare systems, especially in geographies where people participate in sports and leisure activities such as recreational riding, polo, show jumping, and horse racing. These equestrian activities enhance the economic value of horses, allowing owners to invest in healthcare solutions and conveniently accessible services. Moreover, there is an expansion of demand in vaccines, biologics, pharmaceuticals, supplements, and rehabilitation services. As equine sports gain popularity globally, the demand for healthcare providers, product manufacturers, and the sale of medicine is augmented, keeping the growth curve high.

Increasing awareness among pet owners regarding the importance of preventive healthcare is another main factor influencing the market. Owners and trainers extensively use routine veterinary examinations, immunizations, and dietary supplements to preserve longevity and performance. Horses' general health can be improved, and treatment costs can be reduced by taking preventive measures like dental care, parasite control, and early disease identification. In addition, specialized nutritional solutions that promote vitality, immunity, and joint health are growing in popularity. Veterinarian consultations, educational programs, and advancements in equine diagnostic technologies impact this trend. As a result, preventive healthcare is essential to business growth.

Global Equine Healthcare Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global equine healthcare market report based on product, indication, activity, distribution channel, and region:

• Product Outlook (Revenue, USD Million, 2021 - 2033)
• Pharmaceuticals
  • Parasiticides
  • Anti-infectives
  • Anti-inflammatory & Analgesics
  • Other Pharmaceuticals
• Vaccines
• Medicinal Feed Additives
• Orthobiologics
• Diagnostics
  • Diagnostic Test Kits
  • Diagnostics Equipment
• Software & Services
  • Practice Management Software
  • Imaging Software
  • Telehealth Software
  • Other Software
• Others
• Indication Outlook (Revenue, USD Million, 2021 - 2033)
• Musculoskeletal Disorders
• Parasitic Infections
• Equine Herpes Virus
• Equine Viral Arteritis (EVA)
• Equine Influenza
• West Nile Virus
• Tetanus
• Other Indications
• Activity Outlook (Revenue, USD Million, 2021 - 2033)
• Sports/ Racing
• Recreation
• Other Activities
• Distribution Channel Outlook (Revenue, USD Million, 2021 - 2033)
• Veterinary Hospitals & Clinics
• E-commerce
• Equestrian Facilities
• Other Channels
• Regional Outlook (Revenue, USD Million, 2021 - 2033)
• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • UK
  • Germany
  • France
  • Italy
  • Spain
  • Denmark
  • Sweden
  • Norway
• Asia Pacific
  • Japan
  • India
  • China
  • South Korea
  • Australia
  • Thailand
• Latin America
  • Brazil
  • Argentina
• Middle East and Africa (MEA)
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait
  • Qatar
  • Oman

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation and Scope
• 1.2. Market Definitions
• 1.3. Research Methodology
• 1.4. Information Procurement
  • 1.4.1. Purchased Database
  • 1.4.2. GVR's Internal Database
  • 1.4.3. Secondary Sources
  • 1.4.4. Primary Research
• 1.5. Information/Data Analysis
• 1.6. Market Formulation & Visualization
• 1.7. Data Validation & Publishing
• 1.8. Model Details
  • 1.8.1. Commodity flow analysis
  • 1.8.2. Bottom Up Approach
  • 1.8.3. Multivariate Analysis
• 1.9. List of Secondary Sources
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
• 2.3. Competitive Insights

Chapter 3. Equine Healthcare Market Variable Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent Market Outlook
  • 3.1.2. Ancillary Market Outlook
• 3.2. Market Dynamics
  • 3.2.1. Market Driver Analysis
    • 3.2.1.1. Increasing Sports Activities of Equine
    • 3.2.1.2. Rising Awareness of Preventive Healthcare and Nutrition
    • 3.2.1.3. Advances in Veterinary Medicine and Technology
  • 3.2.2. Market Restraint Analysis
    • 3.2.2.1. High Treatment Costs and Limited Accessibility
  • 3.2.3. Market Opportunity Analysis
  • 3.2.4. Market Challenge Analysis
• 3.3. Market Analysis Tools
  • 3.3.1. Porter's Five Forces Analysis
  • 3.3.2. PESTEL by SWOT Analysis
• 3.4. Technology Landscape
• 3.5. Pricing Analysis
• 3.6. Product Pipeline Analysis
• 3.7. Estimated Equine Population by key Countries, 2021 - 2024

Chapter 4. Equine Healthcare Market: Product Estimates & Trend Analysis

• 4.1. Segment Dashboard
• 4.2. Equine Healthcare Market: Product Movement Analysis
• 4.3. Equine Healthcare Market Size & Trend Analysis, by Product, 2021 to 2033 (USD Million)
• 4.4. Pharmaceuticals
  • 4.4.1. Pharmaceuticals Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.4.2. Parasiticides
    • 4.4.2.1. Parasiticides Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.4.3. Anti-infectives
    • 4.4.3.1. Anti-infectives Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.4.4. Anti-inflammatory & Analgesics
    • 4.4.4.1. Anti-inflammatory & Analgesics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.4.5. Other Pharmaceuticals
    • 4.4.5.1. Other Pharmaceuticals Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 4.5. Vaccines
  • 4.5.1. Vaccines Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 4.6. Medicinal Feed Additives
  • 4.6.1. Medicinal Feed Additives Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 4.7. Orthobiologics
  • 4.7.1. Orthobiologics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 4.8. Diagnostics
  • 4.8.1. Diagnostics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.8.2. Diagnostic Test Kits
    • 4.8.2.1. Diagnostic Test Kits Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.8.3. Diagnostics Equipment
    • 4.8.3.1. Diagnostics Equipment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 4.9. Software & Services
  • 4.9.1. Software & Services Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.9.2. Practice Management Software
  • 4.9.3. Practice Management Software Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.9.4. Imaging Software
    • 4.9.4.1. Imaging Software Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.9.5. Telehealth Software
    • 4.9.5.1. Telehealth Software Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.9.6. Other Software
    • 4.9.6.1. Other Software Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 4.10. Others
  • 4.10.1. Others Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 5. Equine Healthcare Market: Indication Estimates & Trend Analysis

• 5.1. Segment Dashboard
• 5.2. Equine Healthcare Market: Indication Movement Analysis
• 5.3. Equine Healthcare Market Size & Trend Analysis, by Indication 2021 to 2033 (USD Million)
• 5.4. Musculoskeletal Disorders
  • 5.4.1. Musculoskeletal Disorders Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 5.5. Parasitic Infections
  • 5.5.1. Parasitic Infections Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 5.6. Equine Herpes Virus
  • 5.6.1. Equine Herpes Virus Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 5.7. Equine Viral Arteritis (EVA)
  • 5.7.1. Equine Viral Arteritis (EVA) Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 5.8. Equine Influenza
  • 5.8.1. Equine Influenza Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 5.9. West Nile Virus
  • 5.9.1. West Nile Virus Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 5.10. Tetanus
  • 5.10.1. Tetanus Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 5.11. Other Indications
  • 5.11.1. Other Indications Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 6. Equine Healthcare Market: By Activity Estimates & Trend Analysis

• 6.1. Segment Dashboard
• 6.2. Equine Healthcare Market: By Activity Movement Analysis
• 6.3. Equine Healthcare Market Size & Trend Analysis, by Activity, 2021 to 2033 (USD Million)
  • 6.3.1. Sports/Racing
    • 6.3.1.1. Sports/Racing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.3.2. Recreation
    • 6.3.2.1. Recreation Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.3.3. Others
    • 6.3.3.1. Others Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 7. Equine Healthcare Market: By Distribution Channel Estimates & Trend Analysis

• 7.1. Segment Dashboard
• 7.2. Equine Healthcare Market: By Distribution Channel Movement Analysis
• 7.3. Equine Healthcare Market Size & Trend Analysis, by Distribution Channel, 2021 to 2033 (USD Million)
  • 7.3.1. Veterinary Hospitals & Clinics
    • 7.3.1.1. Veterinary Hospitals & Clinics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.3.2. E-commerce
    • 7.3.2.1. E-commerce Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.3.3. Equestrian Facilities
    • 7.3.3.1. Equestrian Facilities Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.3.4. Other Channels
    • 7.3.4.1. Other Channels Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 8. Equine Healthcare Market: Regional Estimates & Trend Analysis

• 8.1. Regional Dashboard
• 8.2. Equine Healthcare Market Share, By Region, 2024 & 2033, USD Million
• 8.3. Equine Healthcare Market Size & Trend Analysis, by Region, 2021 to 2033 (USD Million)
• 8.4. North America
  • 8.4.1. North America Equine Healthcare Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.4.2. U.S.
    • 8.4.2.1. Key Country Dynamics
    • 8.4.2.2. Competitive Insights
    • 8.4.2.3. Regulatory Framework
    • 8.4.2.4. U.S. Equine Healthcare Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.4.3. Canada
    • 8.4.3.1. Key Country Dynamics
    • 8.4.3.2. Competitive Insights
    • 8.4.3.3. Regulatory Framework
    • 8.4.3.4. Canada Equine Healthcare Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.4.4. Mexico
    • 8.4.4.1. Key Country Dynamics
    • 8.4.4.2. Competitive Insights
    • 8.4.4.3. Regulatory Framework
    • 8.4.4.4. Mexico Equine Healthcare Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 8.5. Europe
  • 8.5.1. Europe Equine Healthcare Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.5.2. UK
    • 8.5.2.1. Key Country Dynamics
    • 8.5.2.2. Competitive Insights
    • 8.5.2.3. Regulatory Framework
    • 8.5.2.4. UK Equine Healthcare Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.5.3. Germany
    • 8.5.3.1. Key Country Dynamics
    • 8.5.3.2. Competitive Insights
    • 8.5.3.3. Regulatory Framework
    • 8.5.3.4. Germany Equine Healthcare Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.5.4. France
    • 8.5.4.1. Key Country Dynamics
    • 8.5.4.2. Competitive Insights
    • 8.5.4.3. Regulatory Framework
    • 8.5.4.4. France Equine Healthcare Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.5.5. Italy
    • 8.5.5.1. Key Country Dynamics
    • 8.5.5.2. Competitive Insights
    • 8.5.5.3. Regulatory Framework
    • 8.5.5.4. Italy Equine Healthcare Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.5.6. Spain
    • 8.5.6.1. Key Country Dynamics
    • 8.5.6.2. Competitive Insights
    • 8.5.6.3. Regulatory Framework
    • 8.5.6.4. Spain Equine Healthcare Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.5.7. Denmark
    • 8.5.7.1. Key Country Dynamics
    • 8.5.7.2. Competitive Insights
    • 8.5.7.3. Regulatory Framework
    • 8.5.7.4. Denmark Equine Healthcare Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.5.8. Sweden
    • 8.5.8.1. Key Country Dynamics
    • 8.5.8.2. Competitive Insights
    • 8.5.8.3. Regulatory Framework
    • 8.5.8.4. Sweden Equine Healthcare Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.5.9. Norway
    • 8.5.9.1. Key Country Dynamics
    • 8.5.9.2. Competitive Insights
    • 8.5.9.3. Regulatory Framework
    • 8.5.9.4. Norway Equine Healthcare Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 8.6. Asia Pacific
  • 8.6.1. Asia Pacific Equine Healthcare Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.6.2. Japan
    • 8.6.2.1. Key Country Dynamics
    • 8.6.2.2. Competitive Insights
    • 8.6.2.3. Regulatory Framework
    • 8.6.2.4. Japan Equine Healthcare Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.6.3. China
    • 8.6.3.1. Key Country Dynamics
    • 8.6.3.2. Competitive Insights
    • 8.6.3.3. Regulatory Framework
    • 8.6.3.4. China Equine Healthcare Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.6.4. India
    • 8.6.4.1. Key Country Dynamics
    • 8.6.4.2. Competitive Insights
    • 8.6.4.3. Regulatory Framework
    • 8.6.4.4. India Equine Healthcare Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.6.5. Australia
    • 8.6.5.1. Key Country Dynamics
    • 8.6.5.2. Competitive Insights
    • 8.6.5.3. Regulatory Framework
    • 8.6.5.4. Australia Equine Healthcare Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.6.6. South Korea
    • 8.6.6.1. Key Country Dynamics
    • 8.6.6.2. Competitive Insights
    • 8.6.6.3. Regulatory Framework
    • 8.6.6.4. South Korea Equine Healthcare Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.6.7. Thailand
    • 8.6.7.1. Key Country Dynamics
    • 8.6.7.2. Competitive Insights
    • 8.6.7.3. Regulatory Framework
    • 8.6.7.4. Thailand Equine Healthcare Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 8.7. Latin America
  • 8.7.1. Latin America Equine Healthcare Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.7.2. Brazil
    • 8.7.2.1. Key Country Dynamics
    • 8.7.2.2. Competitive Insights
    • 8.7.2.3. Regulatory Framework
    • 8.7.2.4. Brazil Equine Healthcare Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.7.3. Argentina
    • 8.7.3.1. Key Country Dynamics
    • 8.7.3.2. Competitive Insights
    • 8.7.3.3. Regulatory Framework
    • 8.7.3.4. Argentina Equine Healthcare Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 8.8. Middle East & Africa
  • 8.8.1. Middle East & Africa Equine Healthcare Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.8.2. South Africa
    • 8.8.2.1. Key Country Dynamics
    • 8.8.2.2. Competitive Insights
    • 8.8.2.3. Regulatory Framework
    • 8.8.2.4. South Africa Equine Healthcare Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.8.3. Saudi Arabia
    • 8.8.3.1. Key Country Dynamics
    • 8.8.3.2. Competitive Insights
    • 8.8.3.3. Regulatory Framework
    • 8.8.3.4. Saudi Arabia Equine Healthcare Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.8.4. UAE
    • 8.8.4.1. Key Country Dynamics
    • 8.8.4.2. Competitive Insights
    • 8.8.4.3. Regulatory Framework
    • 8.8.4.4. UAE Equine Healthcare Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.8.5. Kuwait
    • 8.8.5.1. Key Country Dynamics
    • 8.8.5.2. Competitive Insights
    • 8.8.5.3. Regulatory Framework
    • 8.8.5.4. Kuwait Equine Healthcare Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.8.6. Qatar
    • 8.8.6.1. Key Country Dynamics
    • 8.8.6.2. Competitive Insights
    • 8.8.6.3. Regulatory Framework
    • 8.8.6.4. Qatar Equine Healthcare Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.8.7. Oman
    • 8.8.7.1. Key Country Dynamics
    • 8.8.7.2. Competitive Insights
    • 8.8.7.3. Regulatory Framework
    • 8.8.7.4. Oman Equine Healthcare Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 9. Competitive Landscape

• 9.1. Market Participant Categorization
  • 9.1.1. Market Leaders
  • 9.1.2. Emerging Players
• 9.2. Company Market Position Analysis/ Heat Map Analysis
• 9.3. Company Profiles
  • 9.3.1. Boehringer Ingelheim International GmbH.
    • 9.3.1.1. Participant's Overview
    • 9.3.1.2. Financial Performance
    • 9.3.1.3. Product Benchmarking
    • 9.3.1.4. Strategic Initiatives
  • 9.3.2. Zoetis Services LLC
    • 9.3.2.1. Participant's Overview
    • 9.3.2.2. Financial Performance
    • 9.3.2.3. Product Benchmarking
    • 9.3.2.4. Strategic Initiatives
  • 9.3.3. Dechra
    • 9.3.3.1. Participant's Overview
    • 9.3.3.2. Financial Performance
    • 9.3.3.3. Product Benchmarking
    • 9.3.3.4. Strategic Initiatives
  • 9.3.4. Arthrex Inc.
    • 9.3.4.1. Participant's Overview
    • 9.3.4.2. Financial Performance
    • 9.3.4.3. Product Benchmarking
    • 9.3.4.4. Strategic Initiatives
  • 9.3.5. Ceva Sante Animale
    • 9.3.5.1. Participant's Overview
    • 9.3.5.2. Financial Performance
    • 9.3.5.3. Product Benchmarking
    • 9.3.5.4. Strategic Initiatives
  • 9.3.6. Heska Corporation
    • 9.3.6.1. Participant's Overview
    • 9.3.6.2. Financial Performance
    • 9.3.6.3. Product Benchmarking
    • 9.3.6.4. Strategic Initiatives
  • 9.3.7. Merck & Co. Inc
    • 9.3.7.1. Participant's Overview
    • 9.3.7.2. Financial Performance
    • 9.3.7.3. Product Benchmarking
    • 9.3.7.4. Strategic Initiatives
  • 9.3.8. Esaote SPA
    • 9.3.8.1. Participant's Overview
    • 9.3.8.2. Financial Performance
    • 9.3.8.3. Product Benchmarking
    • 9.3.8.4. Strategic Initiatives
  • 9.3.9. IDEXX Laboratories, Inc.
    • 9.3.9.1. Participant's Overview
    • 9.3.9.2. Financial Performance
    • 9.3.9.3. Product Benchmarking
    • 9.3.9.4. Strategic Initiatives
  • 9.3.10. Covetrus
    • 9.3.10.1. Participant's Overview
    • 9.3.10.2. Financial Performance
    • 9.3.10.3. Product Benchmarking
    • 9.3.10.4. Strategic Initiatives
  • 9.3.11. Elanco
    • 9.3.11.1. Participant's Overview
    • 9.3.11.2. Financial Performance
    • 9.3.11.3. Product Benchmarking
    • 9.3.11.4. Strategic Initiatives
  • 9.3.12. Cargill
    • 9.3.12.1. Participant's Overview
    • 9.3.12.2. Financial Performance
    • 9.3.12.3. Product Benchmarking
    • 9.3.12.4. Strategic Initiatives
  • 9.3.13. Strategy Mapping
  • 9.3.14. Mergers & Acquisitions
  • 9.3.15. Partnerships & Collaborations
  • 9.3.16. Product launch
  • 9.3.17. Others
• 9.4. List of other key players